natgillin/translations-raw huggingface dataset:
s • chest pain or persistent and severe cough; irregular or rapid heartbeat; shortness of breath, confusion,
Ti zelo resni neželeni učinki so zelo redki. lat Če se pojavi kateri od naslednjih neželenih učinkov, se nemudoma posvetujte s svojim zdravnikom: • bolečine v prsih ali trdovraten in hud kašelj; neredno ali hitro bitje srca; težko dihanje, težava ostati buden, odrevenelost, mravljinci ali bolečina v dlaneh ali stopalih; epileptični napadi up
ori difficulty remaining alert, numbness or tingling sensation or pain in hands or feet; seizure (convulsions); trouble sleeping, thinking or concentrating; altered mental state; suicidal thoughts, suicide attempt, changed behaviour or aggressive behaviour (sometimes directed against others),
(konvulzije); težave z vidom, mišljenjem ali zbranostjo; spremenjeno duševno stanje; samomorilne misli ali poskus samomora, spremenjeno obnašanje ali agresivno obnašanje (včasih odkrito proti drugim), halucinacije; močne želodčne bolečine; črno ali smolnato blato; kri v blatu in seču, huda krvavitev iz nosu; voskasta bledica, visoka raven sladkorja v krvi, zvišana telesna no
uth hallucinations; severe stomach pain; black or tar like stools; blood in stool or urine, severe nosebleed; waxy pallor, high sugar level in blood, fever or chills beginning after a few weeks of treatment, lower back or side pain, difficult urination, problems with your eyes or your eyesight or
temperatura ali mrzlica, ki nastopi po nekaj tednih zdravljenja, bolečina v spodnjem delu hrbta ali ob strani, težave z uriniranjem, težave z očmi ali vidom ali sluhom, izguba sluha, huda ali boleča pordelost ali ranice na koži ali sluznicah. če
Your doctor will test your blood to ensure that your white blood cell (cells that fight infection) and red blood cell (cells that carry iron
Vaš zdravnik bo opravil preiskave krvi, da zagotovi, da je vaše število levkocitov (celice, ki se bojujejo proti on
ge and oxygen) counts, platelets (blood clotting cells) and other laboratory values are at acceptable levels.
okužbi), število eritrocitov (celice z železom za prenos kisika), število trombocitov (celice za strjevanje krvi), pa tudi drugi vaši laboratorijski izvidi sprejemljivi. uk
At the beginning of treatment with Viraferon, you may experience a flu-like reaction, with fever, fatigue, lon headache, muscle ache, joint pain and chills/rigors.
Na začetku zdravljenja z zdravilom Viraferon boste lahko imeli gripi podobno reakcijo z zvišano telesno temperaturo, utrujenostjo, glavobolom, mišičnimi bolečinami, bolečinami v sklepih in mrzlico ali tresenjem.
Your doctor may recommend that you take paracetamol if you develop these symptoms.
Če se pojavijo ti simptomi, vam bo vaš zdravnik lahko priporočil jemanje paracetamola. ks
Other side effects that may occur include: no
Drugi neželeni učinki, ki se lahko pojavijo, so:
Very commonly reported side effects (at least 1 in every 10 patients): pain, swelling and redness or skin damage at site of injection, hair loss, dizziness, changes in appetite, t
Lie
stomach or abdominal pains, diarrhoea, nausea (feeling sick), viral infection, depression, emotional lability, uc
Pri nekaterih otrocih se je upočasnila rast (telesna višina in masa).
insomnia, anxiety, sore throat and painful swallowing, fatigue, chills/rigors, fever, flu-like reaction, feeling of general discomfort, headaches, weight loss, vomiting, irritability, weakness, mood swings, coughing (sometimes severe), shortness of breath, itching, dry skin, rash, sudden and severe muscle pain, joint pain, rod
Pogosto opisani neželeni učinki (pri najmanj 1 na vsakih 100 bolnikov, vendar manj kot 1 na vsakih 10 bolnikov):
musculoskeletal pain, changes in laboratory blood values including decreased white blood cell count.
ie žeja, dehidracija, zvišan krvni tlak, migrene, otekle bezgavke, pordelost, težave z menstruacijo, zmanjšana spolna sla, vaginalne težave, bolečine v dojkah, bolečine v modih, težave z žlezo ščitnico,
Some children have had a decrease in their rate of growth (height and weight). lp
ác pordele dlesni, suha usta, pordela ali vneta usta ali jezik, zobobol ali zobne bolezni, herpes simpleks (vročinske razjede), sprememba okusa, želodčne težave, dispepsija (zgaga), zaprtje, povečanje jeter
Commonly reported side effects (at least 1 in every 100 patients, but less than 1 in every 10 patients): thirst, dehydration, high blood pressure, migraines, swollen glands, flushing, menstrual problems, decreased sexual drive, vaginal problem, breast pain, pain in testicle, problems with thyroid gland, red na
r (jetrne težave, včasih hude), vodeno blato, močenje postelje pri otrocih, vnetje sinusov, bronhitis, očesne
gums, dry mouth, red or sore mouth or tongue, tooth ache or tooth disorder, herpes simplex (fever blisters), taste change, upset stomach, dyspepsia (heartburn), constipation, enlargement of liver (liver problems, sometimes severe), loose stools, bedwetting in children, inflammation of the sinuses, bronchitis, eye pain, i dic
ist bolečine, težave s solznimi kanalčki, konjunktivitis (“ rdeče oko ”), vznemirjenost, zaspanost, hoja v spanju, vedenjske težave, živčnost, zamašen nos ali izcedek iz nosa, kihanje, hitro dihanje, bleda ali pordela koža, podplutbe, velika občutljivost prstov na rokah in nogah na mraz, težave s kožo ali nohti,
Loss of consciousness has occurr ed very rarely, mostly in elderly patients treated at high doses.
Izguba zavesti je nastopila zelo redko, večinoma pri starejših bolnikih, zdravljenih z velikimi odmerki.
Ca ses of stroke (cerebrovascular events) have been reported.
Poročali so o primerih up
ed Periodontal (affecting gums) and dental disorders, altered mental status, loss of consciousness, acute hypersensitivity reactions including urticaria (hives), angioedema (swelling of the hands, feet, ankles, face, lips, mo uth, or throat which may cause difficulty in swallowing or breathing), bronchoconstriction and
Poročali so tudi o periodontalni bolezni (prizadetost dlesni), zobnih boleznih, spremenjenem duševnem stanju, izgubi zavesti ter akutnih preobčutljivostnih reakcijah, vključno z urtikarijo (koprivnica), no
ori Additionally, Vogt-Koyanagi-Ha rada syndrome (an autoimmune inflammatory disorder affecting the eyes, skin and the membranes of the ears, brain and spinal cord) has been reported with Viraferon use.
Poleg tega so pri uporabi zdravila Viraferon poročali tudi o pojavu sindroma Vogt- Koyanagi- Harada (avtoimunska vnetna bolezen, ki prizadene oči, kožo in ušesne membrane ter ovojnice možgan in hrbtenjače). on
The solution should be used immediately after reconstitution.
314 Raztopino morate uporabiti takoj po rekonstituciji.
monohydrate, and human albumin solution.
ur raztopina humanega albumina.
Viraferon is presented as a powder and solvent for solution for injection The white to cream coloured powder is contained in a 2 ml glass vial and the clear and colourless solvent is presented in a 2 ml glass ampoule.
Viraferon je na voljo kot prašek in vehikel za raztopino za injiciranje.
303 Viraferon is available in two different pack sizes:
Prašek bele do krem barve je v 2 ml stekleni viali, bister in brezbarven vehikel pa v 2 ml stekleni ampuli. no Viraferon je na voljo v dveh različnih velikostih pakiranja:
syringe, 2 injection ne edles and 1 cleansing swab
brizga, 2 injekcijski igli in 1 čistilni tampon
ed Marketing Authorisation Holder:
Imetnik dovoljenja za promet z zdravilom:
SP Europe 73, rue de Stalle
SP Europe no
s B-1180 Bruxelles
73, rue de Stalle B- 1180 Bruxelles Belgija
ori Belgium
če
Belgium
Industriepark 30 B- 2220 Heist- op- den- Berg Belgija
For any information about this medicinal product, please contact the local representative of the Marketing
Za vse morebitne nadaljnje informacije o tem zdravilu se lahko obrnete na predstavništvo imetnika dovoljenja za promet z zdravilom: on
uth Authorisation Holder:
België/ Belgique/ Belgien Rue de Stalle/ Stallestraat 73 uk
België/Belgique/Belgien
Luxembourg/ Luxemburg Rue de Stalle 73
ra Rue de Stalle/Stallestraat 73 B-1180 Bruxelles/Brussel/Brüssel Tél/Tel: + 32-(0)2 370 92 11
B- 1180 Bruxelles/ Brussel/ Brüssel Tél/ Tel: + 32 - (0) 2 370 92 11 ks
ge Tél/Tel: + 32-(0)2 370 92 11
B- 1180 Bruxelles/ Brüssel Belgique/ Belgien Tél/ Tel: + 32 - (0) 2 370 92 11
Милко Бичев" № 7, ет.3 BG-София 1504 Тел.: +359 2 944 1073 Česká republika
Милко Бичев "№ 7, ет. 3 Lie
t
315 Tel: +420 221771250
Danmark Lautrupbjerg 2 DK-2750 BallerupTlf: + 45-44 39 50 00 rod
Danmark Lautrupbjerg 2 DK- 2750 Ballerup
Tel: + 31-(0)800 778 78 78 Deutschland Thomas-Dehler-Straße 27
ie Tlf: + 45- 44 39 50 00
Norge Pb.
ác Norge Deutschland Pb.
398
398 Thomas- Dehler- Straße 27
D-81737 München
r N- 1326 Lysaker D- 81737 München
Tel: + 49-(0)89 627
ist Tlf: + 47 67 16 64 50 Tel: + 49 - (0) 89 627 31- 0
Eesti Österreich Järvevana tee 9 EE-11314 Tallinn dic
Österreich Eesti
Badener Strasse 23 A-2514 Traiskirchen
eg Badener Strasse 23 Järvevana tee 9 A- 2514 Traiskirchen EE- 11314 Tallinn Tel: + 43 - (0) 2252 502- 0 Tel: + 372 654 96 86
Tel: + 43-(0)2252 502-0
ur Polska Ελλάδα Al.
Ελλάδα Αγίου Δημητρίου 63 Me
Jerozolimskie 195a Αγίου Δημητρίου 63
GR-174 55 Άλιμος Tηλ: + 30-210 98 97 300
sťo PL- 02- 222 Warszawa GR- 174 55 Άλιμος Tel.: + 48 - (0) 22 478 41 50 Tηλ.: + 30- 210 98 97 300
PL-02-222 Warszawa Tel.: + 48-(0)22 478 41 50
Portugal España no Rua Agualva dos Açores 16 Km.
España Km.
36, Ctra.
Nacional I E-28750 San Agustín de Guadalix – Madrid Tel: + 34-91 848 85 00
Nacional I P- 2735- 557 Agualva- Cacém E- 28750 San Agustín de Guadalix – Madrid Tel: +351- 21 433 93 00 Tel: + 34- 91 848 85 00 lat
304 France 92 rue Baudin F-92300 Levallois-Perret Tél: + 33-(0)1 41 06 35 00
România France up
8, sector 1 RO-013682 Bucureşti Tel. + 40 21 233 35 30
8, sector 1 F- 92300 Levallois- Perret RO- 013682 Bucureşti Tél: + 33 - (0) 1 41 06 35 00 Tel: + 40 21 233 35 30 no
Slovenija
Slovenija Ireland Dunajska 22 Shire Park če
s Tel: + 44-(0)1 707 363 636
SI- 1000 Ljubljana Welwyn Garden City Tel: + 386 01 3001070 Hertfordshire AL7 1TW Tel: +44 - (0) 1 707 363 636 on
Slovenská republika Strakova 5
Slovenská republika Ísland Strakova 5 Hörgatún 2 uk
SK-811 01 Bratislava Tel: + 421 (2) 5920 2712
SK- 811 01 Bratislava IS- 210 Garðabær Tel: + 421 (2) 5920 2712 Sími: + 354 535 70 00 ks
ra Italia Via fratelli Cervi snc, Centro Direzionale Milano Due
Italia Via fratelli Cervi snc, Centro Direzionale Milano Due Lie
ge Palazzo Borromini I-20090 Segrate (Mila no) Tel: + 39-02 21018.1
Puh/ Tel: + 358 - (0) 20- 7570 300 Palazzo Borromini I- 20090 Segrate (Milano) Tel: + 39- 02 21018. 1
Κύπρος Οδός Αγίου Νικολάου, 8 CY-1055 Λευκωσία
316 Sverige Κύπρος Box 6185 Οδός Αγίου Νικολάου, 8 S- 102 33 Stockholm CY- 1055 Λευκωσία Tel: + 46 - (0) 8 522 21 500 Τηλ: +357- 22 757188
Bauskas 58a -401
ie United Kingdom Latvija Shire Park Bauskas 58a - 401
305 Lietuva Kęstučio g.
ist Lietuva Kęstučio g.
65/40 LT-08124 Vilnius Tel. + 370 52 101868
eg LT- 08124 Vilnius Tel. + 370 52 101868
s Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site:
sťo Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila (EMEA) http: // www. emea. europa. eu /. no lat up no če on uk ks Lie
306 HOW TO SELF INJECT VIRAFERON
317 KAKO SI SAMI INJICIRATE ZDRAVILO VIRAFERON
Your doctor or hi s/her assistant will instruct you how to self-inject Viraferon.
Zdravnik ali sestra vas bosta poučila, kako si sami injicirate zdravilo Viraferon.
ed Preparation Collect necessary items before you begin:
ie samoinjiciranje.
- a short needle (for example 0.3 × 13 mm [30 gauge 0.5 inch]) for the subcutaneous injection;
eg za dodajanje vode za injekcije v vialo s praškom zdravila Viraferon; kratko iglo (na primer 0, 3 × 13 mm [vel.
Take the long needle and place it firmly onto the tip of the syringe.
Vzemite dolgo iglo in jo trdno no postavite na vrh brizge.
Break the top of the ampoule of solvent.
Nežno potrkajte po vrhu ampule s topilom, da bo vsa tekočina stekla na dno ampule. lat Odlomite vrh ampule s topilom.
Insert the needle in the ampoule of solvent and withdraw the total amount of solvent. no
Vstavite iglo v ampulo s topilom in posesajte celotno količino topila.
To prepare the Viraferon solution insert the needle through the rubber top of the Viraferon vial and gently place the needle tip against the glass wall of the vial without touching the cleaned top of the vial with your hands. t
Za pripravo raztopine zdravila Viraferon vbodite iglo skozi gumijasti vrh viale z zdravilom Viraferon in up
Do not aim the stream at the white powder at the bottom of the vial.
Da se bo bela vsebina no
To dissolve the white contents, swirl the Viraferon vial with a gentle rotary motion leaving the syringe needle in the vial, until the contents are completely dissolved.
viale zdravila Viraferon raztopila, le- to nežno obračajte, pri čemer naj igla z brizgo ostane v viali, dokler se vsebina viale popolnoma ne raztopi.
If air bubbles do form, wait until the solution has settled and rod
Če zračni mehurčki kljub vsemu nastanejo, počakajte, da se raztopina posede in se vsi mehurčki dvignejo na vrh raztopine ter izginejo, šele potem lahko če
all bubbles have risen to the top of the solution and disappeared before withdrawing your dose from the vial.
posesate odmerek zdravila iz viale.
Be sure the tip of needle is in the Viraferon na
Pazite, da bo vrh igle potopljen v rekonstituirani uk
Your other hand will be free to move the plunger.
raztopini zdravila Viraferon, z drugo roko pa boste premikali bat brizge.
Hold the syringe with the needle in the vial pointing up, remove the syringe from the long needle leaving the i dic
Brizgo z iglo v viali držite obrnjeno navzgor.
needle in the vial and without touching the tip of the syringe.
Snemite brizgo z dolge igle, ki naj ostane v viali, ne da bi se pri tem dotaknili vrha brizge.
Take the short needle and place it firmly onto the tip of the syringe.
Snemite zaščitni ks
Remove the needle guard from the syringe needle and check for air bubbles in the syringe.
pokrovček z igle in preverite, ali so v brizgi morda zračni mehurčki.
Replace the Me
Vrnite zaščitni pokrovček na Lie
needle guard and place the syringe with the needle on a flat surface.
iglo in odložite brizgo z iglo na ravno površino.
307 Injecting the solution Select the injection site.
318 Injiciranje raztopine Izberite si mesto, kamor boste injicirali zdravilo.
ed Clean se and disinfect the skin where the injection is to be made.
ác Očistite in dezinficirajte si kožo na mestu, kjer boste injicirali zdravilo.
INFORMATION FOR THE USER
319 NAVODILO ZA UPORABO
Viraferon, 10 million IU/ml powder and solvent for solution for injection Interferon alfa-2b
Viraferon 10 milijonov i. e. / ml prašek in vehikel za raztopino za injiciranje interferon alfa- 2b
(other than short-term treatment with cortisone-type medicine).
zdravljenja z zdravili, kot je kortizon).
- if you have had serious nervous or ment al problems, such as severe depression or thoughts of suicide.
- če ste kdaj imeli resno živčno ali duševno bolezen, npr. hudo depresijoali samomorilne misli.
- if you develop symptoms associat ed with a cold or other respiratory infection, such as fever, cough, or any
- če se pri vas pojavijo simptomi prehlada ali druge okužbe dihal, npr. zvišana telesna temperatura, kašelj
uth memb ranes of the mouth during long-term treatment with the combination of Viraferon with ribavirin.
Poleg tega bi lahko med dolgotrajnim zdravljenjem s kombinacijo zdravila Viraferon in ribavirina imela škodljiv vpliv na zobe in ustno sluznico tudi suha usta.
could be at increased risk of developing anaemia (low number of red blood cells).
321 kombinaciji z ribavirinom in zidovudinom, se lahko poveča verjetnost za razvoj anemije (majhno število rdečih krvnih celic).
310 Pregnancy and breast -feeding Ask your doctor or pharmacist for advice before taking any medicine.
r ist Nosečnost in dojenje Posvetujte se z zdravnikom ali s farmacevtom, preden vzamete katerokoli zdravilo.
In studies in pregnant animals, interferons have sometimes caus ed miscarriage.
V študijah na brejih živalih so interferoni občasno povzročili splav.
- if you are a girl or a woman of childbearing age, you mu st have a negative pregnancy test before treatment,
- če ste dekle ali ženska v rodni dobi, mora biti nosečnostni test pri vas negativen pred zdravljenjem, vsak
3.
322 3.
311 The usual starting dose for each condition follows; however, individual doses may vary, and the doctor may change your dose based on your specific needs:
eg individualno in zdravnik bo lahko vaš odmerek prilagodil vašim potrebam:
Chronic hepatiti s C:
ur Kronični hepatitis C:
If you are prescribed Vi raferon in combination with another medicine, please refer also to the Package Leaflet of the medicine to be used in combination.
Natančen odmerek in režim odmerjanja zdravil bo določil vaš zdravnik glede na vaše potrebe.
Like all medicines, Viraferon can cause side effects, although not everybody gets them.
323 Kot vsa zdravila ima lahko tudi zdravilo Viraferon neželene učinke, ki pa se ne pojavijo pri vseh bolnikih.
312 If any of the following side effects happen, stop taking Viraferon and tell your doctor immediately or go to the casualty department at your nearest hospital: • swelling of the hands, feet, ankles, face, lips, mouth, or throat which may cause difficulty in swallowing or breathing; hives; fainting.
ur Če se pojavi katerikoli od naštetih neželenih učinkov, prenehajte jemati zdravilo Viraferon in o tem takoj obvestite svojega zdravnika, ali pa pojdite na urgentni oddelek najbližje bolnišnice: • otekanje dlani, stopal, gležnjev, obraza, ustnic, ust ali žrela, ki lahko povzroči težave s požiranjem
You may need urgent medical attention or ho spitalisation.
Morda potrebujete urgentno zdravniško pomoč ali sprejem v bolnišnico.
musculoskeletal pain, changes in laboratory blood values including decreased white blood cell count.
324 mišičnoskeletne bolečine, spremembe izvidov laboratorijskih krvnih preiskav vključno z zmanjšanim številom belih krvničk.
Very rarely sarcoidosis, (a disease characteris ed by persistent fever, weight loss, joint pain and swelling, skin lesions and swollen glands) has been reported.
hujšanje, bolečine v sklepih in otekanje sklepov, kožne lezije in oteklost žlez).
Lo ss of consciousness has occurred very rarely, mostly in elderly patients treated at high doses.
Izguba zavesti je nastopila zelo redko, večinoma pri starejših bolnikih, zdravljenih z velikimi odmerki.
Cases of stroke (cerebrovascular events) have been reported.
Poročali so o primerih up
The solution should be used immediately after reconstitution.
325 Raztopino morate uporabiti takoj po rekonstituciji.
Me
raztopina humanega albumina.
monohydrate, and human albumin solution.
sťo
Viraferon is presented as a powder and solvent for solution for injection The white to cream coloured powder is contained in a 2 ml glass vial and the clear and colourless solvent is presented in a 2 ml glass ampoule.
Viraferon je na voljo kot prašek in vehikel za raztopino za injiciranje Prašek bele do krem barve je v 2 ml stekleni viali, bister in brezbarven vehikel pa v 2 ml stekleni ampuli. lat
314 Viraferon is available in three different pack sizes:
Viraferon je na voljo v treh različnih velikostih pakiranja:
- Pack of 6 vials of powder for solution for injection and 6 ampoules of water for injections
6 vial s praškom za raztopino za injiciranje, 6 ampul vode za injiciranje
- Pack of 10 vials of powder for solution for injection, 10 ampoules of water for injections, 10 injection
10 vial s praškom za raztopino za injiciranje, 10 ampul vode za injiciranje,
syringes, 20 injection needles and 10 cleansing swabs
10 injekcijskih brizg, 20 injekcijskih igel in 10 čistilnih tamponov no
ed Not all pack sizes may be marketed.
Na trgu ni vseh navedenih pakiranj.
Marketing Auth orisation Holder:
Imetnik dovoljenja za promet z zdravilom: če
s SP Europe
SP Europe 73, rue de Stalle B- 1180 Bruxelles
Industriepark 30 B-2220 Heist-op-den-Berg Belgium
Belgija
uth For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder:
Za vse morebitne nadaljnje informacije o tem zdravilu se lahko obrnete na predstavništvo imetnika uk
ra België/Belgique/Belgien Rue de Stalle/Stallestraat 73
dovoljenja za promet z zdravilom:
Luxembourg/Luxemburg Rue de Stalle 73
Luxembourg/ Luxemburg België/ Belgique/ Belgien ks
ge B-1180 Bruxelles/Brussel/Brüssel Tél/Tel: + 32-(0)2 370 92 11
Rue de Stalle 73 Rue de Stalle/ Stallestraat 73 B- 1180 Bruxelles/ Brüssel B- 1180 Bruxelles/ Brussel/ Brüssel Belgique/ Belgien Tél/ Tel: + 32 - (0) 2 370 92 11 Lie
Тел.: +359 2 944 1073 Česká republika Na Příkopě 25
Česká republika
Tel.: + 36 1 457-8500 Malta 168 Christopher Street
Malta
uc
326
MT-VLT02 Valletta
168 Christopher Street Na Příkopě 25 MT- VLT02 Valletta CZ- 110 00 Praha 1 Tel: + 356- 21 23 21 75 Tel: +420 221771250
Nederland
ie Nederland Danmark
Lautrupbjerg 2 DK-2750 Ballerup Tlf: + 45-44 39 50 00 i na dic Me
ác Maarssenbroeksedijk 4 Lautrupbjerg 2 NL- 3542 DN Utrecht DK- 2750 Ballerup
Maarssenbroeksedijk 4 NL-3542 DN Utrecht Tel: + 31-(0)800 778 78 78
r Tel: + 31 - (0) 800 778 78 78 Tlf: + 45- 44 39 50 00
Norge Pb.
ist Norge Deutschland Pb.
398 N-1326 Lysaker Tlf: + 47 67 16 64 50
398 Thomas- Dehler- Straße 27
Ee sti
eg N- 1326 Lysaker D- 81737 München Tlf: + 47 67 16 64 50 Tel: + 49 - (0) 89 627 31- 0
ed Järvevana tee 9 EE-11314 Tallinn Tel: + 372 654 96 86
ur Österreich Eesti Badener Strasse 23 Järvevana tee 9 A- 2514 Traiskirchen EE- 11314 Tallinn
Badener Strasse 23 A-2514 Traiskirchen Tel: + 43-(0)2252 502-0
sťo Tel: + 43 - (0) 2252 502- 0 Tel: + 372 654 96 86
Polska Al.
Polska Ελλάδα Al.
Jerozolimskie 195a PL-02-222 Warszawa
Jerozolimskie 195a Αγίου Δημητρίου 63 no PL- 02- 222 Warszawa GR- 174 55 Άλιμος Tel.: + 48 - (0) 22 478 41 50 Tηλ.: + 30- 210 98 97 300 lat
Tel.: + 48-(0)22 478 41 50
Portugal España Rua Agualva dos Açores 16 Km.
Portugal
Nacional I up
Nacional I E-28750 San Agustín de Guadalix – Madrid Tel: + 34-91 848 85 00
P- 2735- 557 Agualva- Cacém E- 28750 San Agustín de Guadalix – Madrid Tel: +351- 21 433 93 00 Tel: + 34- 91 848 85 00
ge France 92 rue Baudin
România France no
F-92300 Levallois-Perret Tél: + 33-(0)1 41 06 35 00
8, sector 1 F- 92300 Levallois- Perret RO- 013682 Bucureşti Tél: + 33 - (0) 1 41 06 35 00 če
8, sec tor 1 RO-013682 Bucureşti Tel. + 40 21 233 35 30
Tel: + 40 21 233 35 30
Shire Park Welwyn Garden City Hertfordshire AL7 1TW
Shire Park Welwyn Garden City Hertfordshire AL7 1TW uk
Slovenská republika Strakova 5
Slovenská republika Ísland ks
SK-811 01 Bratislava Tel: + 421 (2) 5920 2712
Strakova 5 Hörgatún 2 SK- 811 01 Bratislava IS- 210 Garðabær Tel: + 421 (2) 5920 2712 Sími: + 354 535 70 00 Lie
Via fratelli Cervi Centro Direzionale
Suomi/ Finland Italia PL 3/ PB 3 Via fratelli Cervi snc, FIN- 02201 Espoo/ Esbo Centro Direzionale Milano Due Puh/ Tel: + 358 - (0) 20- 7570 300 Palazzo Borromini I- 20090 Segrate (Milano)
PL 3/PB 3 FIN-02201 Espoo/Esbo
327 Tel: + 39- 02 21018. 1
Palazzo Borromini I-20090 Segrate (Milano) Tel: + 39-02 21018.1 i dic Me
Κύπρος Οδός Αγίου Νικολάου, 8 CY- 1055 Λευκωσία
Puh/Tel: + 358-(0)20-7570 300
Sverige Box 6185 S- 102 33 Stockholm
316 Κύπρος Οδός Αγίου Νικολάου, 8 CY-1055 Λευκωσία Τηλ: + 357-22 757188
ie Τηλ: +357- 22 757188
United Kingdom Shire Park
ác United Kingdom Latvija Shire Park Bauskas 58a - 401
ed Rīga, LV-1004 Tel: + 371-7 21 38 25
r Welwyn Garden City Rīga, LV- 1004
Welwyn Garden City Hertfordshire AL7 1TW - UK Tel: + 44-(0)1 707 363 636
ist Hertfordshire AL7 1TW - UK Tel: + 371- 7 21 38 25 Tel: + 44 - (0) 1 707 363 636
s ori Lietuva Kęstučio g.
eg Lietuva Kęstučio g.
uth Tel. + 370 52 101868
ur Tel. + 370 52 101868
ra This leafle t was last approved on
sťo Navodilo je bilo odobreno
ge Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site: http://www.emea.europa.eu/
Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila (EMEA) http: // www. emea. europa. eu /. no lat up no če on uk ks Lie
317 HOW TO SELF INJECT VIRAFERON
328 KAKO SI SAMI INJICIRATE ZDRAVILO VIRAFERON
318 Injecting the solution Select the injection site.
329 Injiciranje raztopine Izberite si mesto, kamor boste injicirali zdravilo.